Steve Race Alert Sample


Alert Sample

View the Parallel Parliament page for Steve Race

Information between 15th September 2025 - 15th October 2025

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.


Division Votes
15 Sep 2025 - Employment Rights Bill - View Vote Context
Steve Race voted Aye - in line with the party majority and in line with the House
One of 300 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 328 Noes - 160
15 Sep 2025 - Employment Rights Bill - View Vote Context
Steve Race voted Aye - in line with the party majority and in line with the House
One of 303 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 314 Noes - 178
15 Sep 2025 - Employment Rights Bill - View Vote Context
Steve Race voted Aye - in line with the party majority and in line with the House
One of 304 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 327 Noes - 164
15 Sep 2025 - Employment Rights Bill - View Vote Context
Steve Race voted Aye - in line with the party majority and in line with the House
One of 301 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 329 Noes - 163
15 Sep 2025 - Employment Rights Bill - View Vote Context
Steve Race voted Aye - in line with the party majority and in line with the House
One of 300 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 326 Noes - 160
15 Sep 2025 - Employment Rights Bill - View Vote Context
Steve Race voted Aye - in line with the party majority and in line with the House
One of 300 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 316 Noes - 172
15 Sep 2025 - Employment Rights Bill - View Vote Context
Steve Race voted Aye - in line with the party majority and in line with the House
One of 300 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 330 Noes - 158
15 Sep 2025 - Employment Rights Bill - View Vote Context
Steve Race voted Aye - in line with the party majority and in line with the House
One of 302 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 330 Noes - 161
15 Sep 2025 - Employment Rights Bill - View Vote Context
Steve Race voted Aye - in line with the party majority and in line with the House
One of 302 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 330 Noes - 161
15 Sep 2025 - Employment Rights Bill - View Vote Context
Steve Race voted Aye - in line with the party majority and in line with the House
One of 301 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 316 Noes - 161
15 Sep 2025 - Employment Rights Bill - View Vote Context
Steve Race voted Aye - in line with the party majority and in line with the House
One of 304 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 332 Noes - 160
15 Sep 2025 - Employment Rights Bill - View Vote Context
Steve Race voted Aye - in line with the party majority and in line with the House
One of 302 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 318 Noes - 170
16 Sep 2025 - Sentencing Bill - View Vote Context
Steve Race voted Aye - in line with the party majority and in line with the House
One of 278 Labour Aye votes vs 0 Labour No votes
Tally: Ayes - 340 Noes - 77
16 Sep 2025 - Sentencing Bill - View Vote Context
Steve Race voted No - in line with the party majority and in line with the House
One of 277 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 78 Noes - 292
14 Oct 2025 - Mental Health Bill [Lords] - View Vote Context
Steve Race voted No - in line with the party majority and in line with the House
One of 320 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 163 Noes - 339
14 Oct 2025 - Mental Health Bill [Lords] - View Vote Context
Steve Race voted No - in line with the party majority and in line with the House
One of 318 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 78 Noes - 327
14 Oct 2025 - Mental Health Bill [Lords] - View Vote Context
Steve Race voted No - in line with the party majority and in line with the House
One of 320 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 164 Noes - 333


Written Answers
Development Aid: Nutrition
Asked by: Steve Race (Labour - Exeter)
Wednesday 17th September 2025

Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what estimate he has made of the level of therapeutic food procured through UK Overseas Development Assistance (a) directly by the Government and (b) by third party partners, in the latest year for which information is available.

Answered by Chris Elmore - Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)

The Foreign, Commonwealth and Development Office (FCDO) does not directly procure therapeutic foods and does not currently hold data on the quantity of therapeutic foods procured by third-party partners using FCDO funds.

Therapeutic foods are primarily procured as part of nutrition-related humanitarian programming. Expenditure on nutrition-related humanitarian programming is captured in the FCDO's annual nutrition accountability reports, which are published 18 months in arrears. The most recent report covers spend from 2022, totalling £238.5 million. This figure which includes funding for food assistance and therapeutic foods, should be viewed as a proxy indicator of the level of investment in such products, rather than a direct measure of procurement. Data on nutrition-related spend for 2023 will be published in Autumn 2025.




Steve Race - Select Committee Information

Calendar
Tuesday 14th October 2025 9 a.m.
Science, Innovation and Technology Committee - Oral evidence
Subject: Innovation showcase
At 9:30am: Oral evidence
Dr Sebastian Weidt - Co-Founder and CEO at Universal Quantum
At 9:45am: Oral evidence
Nick Davies - Programme Director at Institute for Government
Jason Liggins - CEO at Crown Hosting Data Centres
At 10:30am: Oral evidence
Gaia Marcus - Director at Ada Lovelace Institute
Jeni Tennison - Executive Director at Connected by Data
View calendar - Add to calendar
Tuesday 21st October 2025 9 a.m.
Science, Innovation and Technology Committee - Oral evidence
Subject: Innovation showcase
At 9:30am: Oral evidence
Professor Mahesh Anand - Professor at Planetary Science and Exploration and Director of Research at the School of Physical Sciences, The Open University
At 9:45am: Oral evidence
John Edwards - Information Commissioner at Information Commissioner's Office (ICO)
View calendar - Add to calendar
Tuesday 28th October 2025 9 a.m.
Science, Innovation and Technology Committee - Oral evidence
Subject: Life sciences investment
At 9:30am: Oral evidence
Emily Hyett - Group Product Manager at Yoti
At 9:45am: Oral evidence
Dr Sam Roberts - Chief Executive at NICE
At 10:30am: Oral evidence
The Lord Vallance of Balham KCB - Minister for Science, Research and Innovation at Department for Science, Innovation and Technology
Steve Bates - Executive Chairman at Office for Life Sciences
Dr Zubir Ahmed MP - Parliamentary Under-Secretary of State at Department of Health and Social Care
View calendar - Add to calendar
Tuesday 4th November 2025 9 a.m.
Science, Innovation and Technology Committee - Oral evidence
Subject: Innovation and global food security
View calendar - Add to calendar


Select Committee Documents
Wednesday 3rd September 2025
Oral Evidence - ARIA, and ARIA

Science, Innovation and Technology Committee
Tuesday 16th September 2025
Oral Evidence - DSIT, Office for Life Sciences, and Department of Health and Social Care (DHSC)

Science, Innovation and Technology Committee
Tuesday 16th September 2025
Oral Evidence - MSD, ABPI (The Association of the British Pharmaceutical Industry), and AstraZeneca

Science, Innovation and Technology Committee
Wednesday 15th October 2025
Correspondence - Correspondence from Minister for AI and Online Safety, re: Government response to committee’s social media, misinformation and harmful algorithms report, 18 September 2025

Science, Innovation and Technology Committee
Wednesday 15th October 2025
Correspondence - Correspondence from Minister for Digital Economy, re: Cyber Growth Action Plan, 19 September 2025

Science, Innovation and Technology Committee
Wednesday 15th October 2025
Correspondence - Correspondence from Secretary of State for Science, Innovation and Technology, re; National Digital Identity Programme, 26 September 2025

Science, Innovation and Technology Committee
Tuesday 14th October 2025
Oral Evidence - Institute for Government, and Crown Hosting Data Centres

Digital centre of government - Science, Innovation and Technology Committee
Tuesday 14th October 2025
Oral Evidence - Ada Lovelace Institute, and Connected by Data

Digital centre of government - Science, Innovation and Technology Committee
Tuesday 14th October 2025
Oral Evidence - Universal Quantum

Innovation showcase - Science, Innovation and Technology Committee
Friday 17th October 2025
Special Report - 3rd Special Report - Social media, misinformation and harmful algorithms: Government and Ofcom responses

Science, Innovation and Technology Committee
Monday 20th October 2025
Correspondence - Correspondence from the Government Chief Technology Officer, re: Information security standards, 20 October 2025

Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Eli Lilly and Company
LSI0052 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - AbbVie Inc.
LSI0053 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Kidney Research UK
LSI0051 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Cyted Health
LSI0034 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Johnson & Johnson MedTech
LSI0035 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Blood Cancer Alliance
LSI0033 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Office for Life Sciences, HM Government
LSI0044 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - British In Vitro Diagnostics Association (BIVDA)
LSI0043 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Genetic Alliance UK
LSI0041 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Novartis
LSI0018 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Moderna
LSI0019 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Urology Trade Association
LSI0020 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Autolus Therapeutics
LSI0056 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - The Institute of Biomedical Science
LSI0055 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Oxford Endovascular Ltd
LSI0054 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Association of British HealthTech Industries (ABHI)
LSI0037 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Myeloma UK
LSI0036 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Teva UK Ltd
LSI0040 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Medical Technology Group (MTG)
LSI0038 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Glaukos Corporation
LSI0039 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - The Association of the British Pharmaceutical Industry (ABPI)
LSI0016 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - U-Ploid Biotechnologies
LSI0017 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Zimmer Biomet
LSI0045 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Wellcome Trust
LSI0022 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Medicines UK
LSI0047 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Smith+Nephew
LSI0046 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - The University of Manchester
LSI0049 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Alzheimers Research UK
LSI0048 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Youth Accessibility Network (youth-led coalition)
LSI0050 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Sanofi
LSI0028 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Johnson & Johnson Innovative Medicine UK (Janssen Cilag Ltd)
LSI0029 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Incyte Biosciences UK
LSI0030 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - University of Oxford
LSI0001 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - techUK
LSI0015 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Correspondence - Correspondence from Minister for Digital Economy, re: The Product Security and Telecommunications Infrastructure (Security Requirements for Relevant Connectable Products) (Amendment) (No. 2) Regulations 2025, 13 October 2025

Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Becton Dickinson UK Limited
LSI0006 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - International Porphyria Patient Network (IPPN)
LSI0011 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Roche Diagnostics
LSI0009 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - University of Dundee
LSI0010 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Peninsula Technology Assessment Group (PenTAG), University of Exeter
LSI0025 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Association of Medical Research Charities
LSI0023 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Essity
LSI0021 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Daiichi Sankyo
LSI0027 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Academy of Medical Sciences
LSI0008 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Juniper
LSI0007 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Yorkshire Cancer Research
LSI0005 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Centre for Sectoral Economic Performance (CSEP), Imperial College, London
LSI0002 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - IQVIA
LSI0003 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - UCB Ph
LSI0026 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - NICE (National Institute for Health and Care Excellence)
LSI0024 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Correspondence - Correspondence from the Chief Secretary to the Prime Minister and Chancellor of the Duchy of Lancaster, re: Government commitment to information security, 13 October 2025

Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Chiesi Ltd
LSI0013 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Ipsen
LSI0012 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - Cambridge University Health Partners
LSI0014 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Wednesday 22nd October 2025
Written Evidence - UK BioIndustry Association
LSI0032 - Life sciences investment

Life sciences investment - Science, Innovation and Technology Committee
Friday 24th October 2025
Written Evidence - Metropolitan Police
PHT0012 - Phone theft

Science, Innovation and Technology Committee
Friday 24th October 2025
Written Evidence - Apple
PHT0009 - Phone theft

Science, Innovation and Technology Committee
Friday 24th October 2025
Written Evidence - Google
PHT0010 - Phone theft

Science, Innovation and Technology Committee
Friday 24th October 2025
Written Evidence - Samsung Electronics UK
PHT0011 - Phone theft

Science, Innovation and Technology Committee
Friday 24th October 2025
Correspondence - Correspondence from Chair, re: Mobile phone theft, 23 October 2025

Science, Innovation and Technology Committee
Tuesday 21st October 2025
Oral Evidence - Planetary Science and Exploration and Director of Research at the School of Physical Sciences, The Open University

Innovation showcase - Science, Innovation and Technology Committee
Tuesday 21st October 2025
Oral Evidence - Information Commissioner's Office (ICO)

Science, Innovation and Technology Committee


Select Committee Inquiry
2 Oct 2025
Life sciences investment
Science, Innovation and Technology Committee (Select)
Not accepting submissions

With MSD cancelling its £1 billion ongoing manufacturing site in Kings Cross, AstraZeneca pausing its £200 million investment in its Cambridge site, and the latter upgrading its US listing, the Science, Innovation and Technology Committee is launching a call for evidence on UK life sciences competitiveness.

This follows an initial emergency session, where it heard from representatives from MSD and AstraZeneca, as well as the ABPI, and from officials and ministers, including Minister for Science, Research and Innovation, Patrick Vallance. 

The call for written evidence will examine the competitiveness of the UK’s life sciences sector, barriers to innovation for medicines in the UK, issues with pricing uptake and access, and the impact of other countries’ policies.